Phathom Pharmaceuticals Inc (PHAT)
10.69
0.00 (0.00%)
USD |
NASDAQ |
May 17, 09:57
Phathom Pharmaceuticals Market Cap: 625.74M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 625.74M |
| May 15, 2024 | 609.35M |
| May 14, 2024 | 608.18M |
| May 13, 2024 | 566.04M |
| May 10, 2024 | 557.55M |
| May 09, 2024 | 590.62M |
| May 08, 2024 | 591.21M |
| May 07, 2024 | 599.40M |
| May 06, 2024 | 634.52M |
| May 03, 2024 | 587.58M |
| May 02, 2024 | 571.20M |
| May 01, 2024 | 541.93M |
| April 30, 2024 | 528.47M |
| April 29, 2024 | 547.20M |
| April 26, 2024 | 537.25M |
| April 25, 2024 | 532.57M |
| April 24, 2024 | 533.74M |
| April 23, 2024 | 530.23M |
| April 22, 2024 | 527.30M |
| April 19, 2024 | 524.96M |
| April 18, 2024 | 554.81M |
| April 17, 2024 | 573.54M |
| April 16, 2024 | 587.00M |
| April 15, 2024 | 586.41M |
| April 12, 2024 | 593.43M |
| Date | Value |
|---|---|
| April 11, 2024 | 612.75M |
| April 10, 2024 | 690.58M |
| April 09, 2024 | 705.22M |
| April 08, 2024 | 650.20M |
| April 05, 2024 | 645.52M |
| April 04, 2024 | 632.06M |
| April 03, 2024 | 577.05M |
| April 02, 2024 | 573.54M |
| April 01, 2024 | 620.36M |
| March 28, 2024 | 621.53M |
| March 27, 2024 | 646.18M |
| March 26, 2024 | 614.01M |
| March 25, 2024 | 611.09M |
| March 22, 2024 | 644.42M |
| March 21, 2024 | 535.65M |
| March 20, 2024 | 533.31M |
| March 19, 2024 | 504.08M |
| March 18, 2024 | 484.19M |
| March 15, 2024 | 496.47M |
| March 14, 2024 | 454.37M |
| March 13, 2024 | 467.82M |
| March 12, 2024 | 477.76M |
| March 11, 2024 | 483.02M |
| March 08, 2024 | 519.28M |
| March 07, 2024 | 531.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
242.25M
Minimum
Jun 14 2022
1.388B
Maximum
Mar 09 2021
708.17M
Average
637.44M
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 106.86B |
| Ocular Therapeutix Inc | 952.57M |
| Rhythm Pharmaceuticals Inc | 2.378B |
| Xeris Biopharma Holdings Inc | 297.99M |
| Gritstone Bio Inc | 82.51M |
Market Cap Related Metrics
| Price | 10.69 |
| Earnings Yield | -41.81% |